Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology, Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2015 |
| Start Date: | September 2013 |
| Contact: | Theodore Leng, MD |
| Phone: | 6507236995 |
Patients with diabetic macular edema who were switched to aflibercept after having been
treated with bevacizumab or ranibizumab were retrospectively reviewed to assess for visual
acuity and anatomic outcomes.
treated with bevacizumab or ranibizumab were retrospectively reviewed to assess for visual
acuity and anatomic outcomes.
Inclusion Criteria: Those patients with diabetic macular edema switched to aflibercept
from bevacizumab and/or ranibizumab -
Exclusion Criteria: None
-
We found this trial at
1
site
Click here to add this to my saved trials
